Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
| Image |  |
|---|---|
| Description | scientific article published on 29 January 2022 |
| Author/s |
author: Daniela Stadler Ulrike Protzer |
| Publication date | January 29, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |